Neuropathological Characterization
Neuropathological Characterization - Related Videos
07:30
A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments
0 Views •
Cited by 11 •
2017
This report outlines a simple approach to successfully induce experimental autoimmune neuritis (EAN) using the myelin protein zero (P0)180-199 peptide in combination with Freund's complete adjuvant and pertussis toxin. We present a sophisticated paradigm capable of accurately assessing the extent of functional deficits and neuropathology that occur in this EAN.
10:02
Assessment of Spontaneous Alternation, Novel Object Recognition and Limb Clasping in Transgenic Mouse Models of Amyloid-β and Tau Neuropathology
0 Views •
Cited by 199 •
2017
Described here is a staged, behavioral screening approach that can be used to screen for compounds that exhibit in vivo efficacy on cognitive and functional motor behaviors in transgenic mouse models of β-amyloidosis and tauopathy. These methods are optimized to screen compounds for activity in short-term and working memory tasks.
14:33
Generation, Purification, and Characterization of Cell-invasive DISC1 Protein Species
0 Views •
Cited by 13 •
2012
The generation, purification and cell invasion of intracellular, cytoplasmic full length DISC1 protein aggresomes from cell cultures and of a labeled, multimeric recombinant DISC1 protein fragment in E. coli are described. Cell invasiveness is shown for recipient cells in cell culture and for neurons in vivo after stereotactical brain inoculation.
10:41
Characterization of Magnetic Components
0 Views •
2023
Source: Ali Bazzi, Department of Electrical Engineering, University of Connecticut, Storrs, CT. The objective of this experiment is to achieve hands-on experience with different magnetic components from design and material perspectives. This experiment covers B-H curves of magnetic material and inductor design through identifying unknown design factors. The B-H curve of a magnetic element, such as an inductor or transformer, is a characteristic of the magnetic material forming the core around...
10:24
A Method for Characterizing Embryogenesis in Arabidopsis
0 Views •
Cited by 11 •
2017
This protocol outlines a method for observing embryogenesis in Arabidopsis via ovule clearance followed by the inspection of embryo pattern formation under a microscope.
FAQs
It integrates clinical information with observations made at several biological scales. Gross examination provides an overall view of affected regions, while histology and microscopy reveal cellular and tissue changes. Immunohistochemistry and molecular testing add information about particular proteins or molecular features. Combining these results helps relate visible pathology to disease-associated changes in nervous system structure and function.
Interpretation focuses on the distribution and type of abnormality rather than on a single finding. Patterns may include neuronal loss, protein accumulation, inflammation, vascular damage, or tissue degeneration, affecting particular brain regions or cell populations. Comparing these patterns helps characterize disease-associated pathology, classify disorders, and clarify whether different conditions involve distinct structural changes.
Each represents a different level at which nervous system pathology may appear. Neuronal loss can indicate damage to nerve cells, while changes involving glial cells, synapses, or specific brain regions provide additional context about affected tissue. Examining these components together helps connect cellular abnormalities with broader patterns of degeneration and with nervous system function.
The process begins by considering the clinical information and examining nervous system tissue grossly. Investigators then apply histology and microscopic analysis to evaluate tissue organization and cellular changes. Immunohistochemistry can assess selected protein-related features, and molecular testing adds complementary evidence. The findings are integrated to describe abnormalities and determine their relevance to disease or injury.
It supports diagnosis and disease classification by documenting characteristic patterns of nervous system abnormality. In research, the same evidence helps investigate disease mechanisms and identify potential therapeutic targets. Because the approach examines structural, cellular, and molecular findings together, it can connect observed pathology with broader questions about neurodegeneration, injury, and nervous system dysfunction.
Researchers can compare nervous system pathology after treatment with the abnormalities associated with disease or injury. Histology, immunohistochemistry, molecular testing, and microscopic analysis may reveal changes in neuronal loss, protein accumulation, inflammation, vascular damage, or tissue degeneration. These observations provide pathology-based evidence for assessing whether an experimental intervention alters disease-related nervous system changes.